Enanta Pharmaceuticals to Present at Two Upcoming Investor Conferences
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
Enanta Pharma (ENTA) Misses Q1 EPS by 8c
February 8, 2017 4:03 PM ESTEnanta Pharma (NASDAQ: ENTA) reported Q1 EPS of ($0.26), $0.08 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $11.9 million versus the consensus estimate of $11.94 million.
For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.
... More
